公司资料
Cardinal Health 股价、新闻与催化剂
- 股票代码:
- CAH
- 交易所:
- NYSE
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
232.37 USD (+1.25%)
收盘价
最后更新: 2026年8月24日
45.6B USD
市值
股价为何变动
As of Aug 24, 2026, CAH closed up 1.25% at $232.37. No new same-company headline was identified in the current news window.
公司概览
业务概览
Cardinal Health is a major healthcare services and distribution company that helps move pharmaceuticals and medical products through the supply chain. Its business is centered on logistics, distribution, and specialty services rather than product invention.
所在地与行业分类
Headquartered in the United States and listed on NYSE, Cardinal Health has a large domestic footprint with international exposure in healthcare distribution. It sits in infrastructure and services, not biotech.
商业模式特征
The company earns revenue from pharmaceutical distribution, medical products, and related healthcare services. Investors focus on distribution volumes, margin stability, and the economics of specialty and hospital channels.
生物医药行业定位
Cardinal Health is outside biotech, but it is important to the sector because distribution and access are essential to how therapies reach patients. It is more of a healthcare infrastructure name than an innovation stock.
未来催化剂
- Cardinal Health’s catalysts are specialty-distribution execution, pharma supply-chain normalization, and margin improvement across the distribution network. That matters because demand only becomes valuable if the company can actually deliver at scale. Any improvement in supply or capacity can change how investors think about the next leg of the revenue curve.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。